Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 1 or 2 Diabetics”

49 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 49 results

Testing effectiveness (Phase 2)WithdrawnNCT04661917
What this trial is testing

A Trial to Learn More About How BAY2327949 Works and How Safe it is in Patients Whose Kidneys Are Damaged Due to High Blood Sugar Levels or High Blood Pressures, and With a Further Disease of the Heart or the Blood Vessels.

Who this might be right for
Chronic Kidney DiseaseDiabetic Kidney Disease
Bayer
Large-scale testing (Phase 3)Study completedNCT00773279
What this trial is testing

Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in Diabetics

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2+1 more
Novo Nordisk A/S 242
Testing effectiveness (Phase 2)Study completedNCT00320021
What this trial is testing

Effect of Pyridorin in Patients With Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
BioStratum 80
Large-scale testing (Phase 3)Study completedNCT01754259
What this trial is testing

Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Diabetic Patients and CAD

Who this might be right for
Diabetes, Type IDiabetes, Type IIAngina+1 more
Brigham and Women's Hospital 47
Testing effectiveness (Phase 2)UnknownNCT05333835
What this trial is testing

A Trial Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd. 455
Large-scale testing (Phase 3)Study completedNCT01766362
What this trial is testing

Incidence of Macular Edema After Panretinal Photocoagulation (PRPC) Performed in a Single Session Versus Four Sessions in Diabetic Patients.

Who this might be right for
Diabetes Type 1 or 2 With Diabetic Retinopathy
Centre Hospitalier Universitaire Dijon 83
Testing effectiveness (Phase 2)Study completedNCT00375960
What this trial is testing

A Research Study of V3381 for the Treatment of Diabetic Peripheral Neuropathic Pain

Who this might be right for
PainDiabetic Neuropathies
Vernalis (R&D) Ltd 50
Large-scale testing (Phase 3)Study completedNCT00191581
What this trial is testing

Local Registration Trial in China Humalog Mix 50

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Eli Lilly and Company 120
Testing effectiveness (Phase 2)Study completedNCT01079325
What this trial is testing

Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetic Polyneuropathy
Sangamo Therapeutics 170
Post-approval studies (Phase 4)Study completedNCT00420095
What this trial is testing

Patients With Diabetes Mellitus (IOPA)

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Eli Lilly and Company 117
Testing effectiveness (Phase 2)Ended earlyNCT01069965
What this trial is testing

Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
N-Gene Research Laboratories, Inc. 196
Not applicableWithdrawnNCT05791929
What this trial is testing

LSCI and Thermography in Diabetic Foot Patients Affected by Ulcer(s): (MY-FOOT-B)

Who this might be right for
Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1Ulcer Foot
Mario Negri Institute for Pharmacological Research
Not applicableStudy completedNCT01460446
What this trial is testing

ACCU-CHEK® Aviva Expert Study: Does Use of a Bolus Advisor Improve Glycemic Control in Patients Not Achieving Optimal Control Using Multiple Daily Injections (MDI)?

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Hoffmann-La Roche 218
Large-scale testing (Phase 3)Study completedNCT01336023
What this trial is testing

Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 1,663
Not applicableWithdrawnNCT01978990
What this trial is testing

Assessment of a Health Informatics System on Insulin-treated Diabetic Patients

Who this might be right for
Type 1 or 2 Diabetics
Hadassah Medical Organization
Not applicableStudy completedNCT01487408
What this trial is testing

Special Survey for Type 1 or Type 2 Diabetic Patients

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 1,463
Large-scale testing (Phase 3)Ended earlyNCT00138671
What this trial is testing

A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD

Who this might be right for
Diabetes MellitusChronic Obstructive Pulmonary Disease
Pfizer 105
Not applicableStudy completedNCT00286572
What this trial is testing

Long-term Mortality in Diabetics Undergoing Major Surgery

Who this might be right for
Diabetes MellitusCoronary Heart DiseaseMajor Non-cardiac Surgery
University Hospital, Basel, Switzerland 380
Large-scale testing (Phase 3)Study completedNCT01467323
What this trial is testing

Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 303
Early research (Phase 1)Study completedNCT06648031
What this trial is testing

Comparison of the Safety, Efficacy and Pharmacokinetics of DehydraTECH -CBD and DehydraTECH-GLP1 Agonists Alone or in Combination, in Overweight or Obese, Pre- and Type 2 Diabetic Participants

Who this might be right for
Type2diabetes
Lexaria Bioscience Corp. 148
Next Page